GivBux Inc filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 20, 2026, reporting financial results for the three and nine months ended September 30, 2026.
Key Highlights
- Quarterly net loss: GivBux recorded a net loss of $2,231,644 for the three months ended September 30, 2026, compared to net income of $3,339,513 in the same quarter of 2025.
- Nine-month net loss: For the nine months ended September 30, 2026, the company reported a net loss of $2,986,814, according to the filing.
- Revenue declined: Quarterly revenue was $57,857 for Q3 2026, down from $89,988 in Q3 2025; nine-month revenue was $148,027 versus $211,814 in the prior-year period.
- Derivative liabilities: Derivative liabilities totaled $3,045,852 as of September 30, 2026, up from $1,156,230 at December 31, 2025.
- Accumulated deficit: The accumulated deficit stood at $37,183,604 as of September 30, 2026, compared to $34,196,790 at December 31, 2025.
- Total stockholders' deficit: Total stockholders' deficit was $7,150,640 at September 30, 2026, widening from $4,945,397 at December 31, 2025.
- Shares outstanding: 536,022,153 shares of common stock were outstanding as of November 6, 2026, with 487,022,153 shares issued and outstanding as of September 30, 2026.
GivBux Q3 2026 Financial Results: Revenue, Losses, and Balance Sheet Pressures
According to the filing, GivBux Inc (OTC Pink:GBUX), a Nevada-incorporated company headquartered in Henderson, Nevada, reported a net loss of $2,231,644 for the three months ended September 30, 2026. This compares to net income of $3,339,513 in the same quarter of 2025, a figure the company attributed primarily to a large favorable change in the fair value of derivative liabilities in that prior period. For Q3 2026, the change in fair value of derivative liabilities was an unfavorable $(1,828,380), contributing substantially to the quarter's total other expense of $(2,099,973).
The filing disclosed that quarterly revenue fell to $57,857 from $89,988 in Q3 2025, while cost of revenue was $33,335, producing gross profit of $24,522. Total operating expenses for the quarter were $156,193, resulting in a loss from operations of $131,671. For the nine months ended September 30, 2026, the company reported a net loss of $2,986,814 on revenue of $148,027. Interest expense for the nine-month period was $677,968, and loss on conversion of convertible notes was $121,477, according to the filing.
On the balance sheet, the company disclosed total assets of $94,358 as of September 30, 2026, down from $242,685 at December 31, 2025, with cash of $23,868. Total current liabilities reached $7,244,998, driven in part by convertible notes (net of discount of $547,637) of $1,473,007 and derivative liabilities of $3,045,852. The company issued 1,000,000 shares of Series C Preferred Stock during the nine-month period in exchange for a due-to-related-party balance. Common stock authorized was increased to 11,490,000,000 shares from 100,000,000 shares, as stated in the filing. The company is classified as a smaller reporting company and an emerging growth company.
What Was Disclosed
GivBux Inc disclosed unaudited consolidated financial statements for the quarter and nine months ended September 30, 2026, showing declining revenue, a widening accumulated deficit of $37,183,604, expanded derivative liabilities, and a total stockholders' deficit of $7,150,640 as of that date.




Please wait processing your request...